Results 71 to 80 of about 6,742 (131)

Development and evaluation of a CEACAM6-targeting theranostic nanomedicine for photoacoustic-based diagnosis and chemotherapy of metastatic cancer. [PDF]

Theranostics, 2018
Lee H, Jang Y, Park S, Jang H, Park EJ, Kim HJ, Kim H.   +6 more
europepmc   +1 more source

Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene-docetaxel conjugate. [PDF]

Int J Nanomedicine, 2017
Jun YJ, Park JH, Avaji PG, Park KS, Lee KE, Lee HJ, Sohn YS.   +6 more
europepmc   +1 more source

Multimodal theranostic nanoplatforms for nanomedicine applications

, 2022
Targeted nanoparticle (NP)-based drug delivery has emerged with significant potential for nanomedicine [1]. Compared with other intensively studied noble metal nanomaterials, such as Au and Ag, Pd NPs exhibit distinctive features, including high photothermal conversion efficiency and chemical stability, remarkable photocatalytic activity, other than ...
openaire   +1 more source

A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy. [PDF]

Theranostics, 2018
Li X, Schumann C, Albarqi HA, Lee CJ, Alani AWG, Bracha S, Milovancev M, Taratula O, Taratula O.   +8 more
europepmc   +1 more source

A smart and versatile theranostic nanomedicine platform based on nanoporphyrin. [PDF]

Nat Commun, 2014
Li Y, Lin TY, Luo Y, Liu Q, Xiao W, Guo W, Lac D, Zhang H, Feng C, Wachsmann-Hogiu S, Walton JH, Cherry SR, Rowland DJ, Kukis D, Pan C, Lam KS.   +15 more
europepmc   +1 more source

Design of a novel theranostic nanomedicine: synthesis and physicochemical properties of a biocompatible polyphosphazene-platinum(II) conjugate. [PDF]

Int J Nanomedicine, 2016
Avaji PG, Park JH, Lee HJ, Jun YJ, Park KS, Lee KE, Choi SJ, Lee HJ, Sohn YS.   +8 more
europepmc   +1 more source

AI and organoid platforms for brain-targeted theranostics. [PDF]

Theranostics
Ye R, Zhang Y, Xu W, Lai L, Zhang Z, Chen Y, Qin S.   +6 more
europepmc   +1 more source

Nanomedicine in Ovarian Cancer: Advances in Imaging, Targeted Delivery, and Theranostic Therapeutic Platforms. [PDF]

Cancers (Basel)
Bartusik-Aebisher D, Wilk I, Aebisher D.
europepmc   +1 more source

Theranostic Nanoparticles in Prostate Cancer: Disrupting Hypoxia-Induced Glycolysis by Targeting Hypoxia-Inducible Factor-1 Alpha and Downstream Metabolites. [PDF]

Cancer Med
Uti DE, Omang WA, Alum EU, Bawa I, Ugwu OP, Idowu AO, Atangwho IJ, Egbung GE.   +7 more
europepmc   +1 more source

In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine. [PDF]

ACS Nano, 2015
Chen F, Hong H, Goel S, Graves SA, Orbay H, Ehlerding EB, Shi S, Theuer CP, Nickles RJ, Cai W.   +9 more
europepmc   +1 more source